Investor Presentation

05 August, 2026 BSE Limited The National Stock Exchange of India Limited Phiroze Jeejeebhoy Towers, Exchange Plaza, Bandra Kurla Complex, Dalal Street, Mumbai 400001, Bandra (East), Mumbai 400051, Maharashtra, India Maharashtra, India Scrip Code: 540975 Scrip Symbol: ASTERDM Dear Sir/Madam, Sub: Investor Presentation for the quarter ended 30 June 2026 Ref: Our letter dated 31 July 2026, and Regulation 30 read-with Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. With reference to the captioned subject, please find enclosed the Management’s Presentation for the Earnings Conference Call with analysts/ Investors scheduled for 5 August 2026 in relation to the unaudited financial results for the quarter ended 30 June 2026. Kindly take the above-said information on record. Thank you For Aster DM Quality Care Limited (Formerly Aster DM Healthcare Limited) Hemish Purushottam Company Secretary and Compliance Officer M. No. A24331 Earnings Presentation Q1 FY27 Page title 24 pt Disclaimer 22 77 146 Page subtitle 20pt non bold 22 77 146 • This presentation has been prepared by Aster DM Quality Care Limited (the "Company"), content of which was compiled from sources believed to be reliable for Heading informational purposes only and are based on information regarding the Company and the economic, regulatory, market and other conditions as in effect on the date Font color –22 77 146 hereof. Subsequent developments may impact the information contained in this presentation, which neither the Company nor its advisors or representatives are under Line: 22 77 146 an obligation to update, revise or affirm. Contents in the Presentation do not constitute or form part of an offer or invitation for sale or subscription of or solicitation or Excel color scheme invitation of any offer to buy or subscribe for any securities, nor shall it or any part of it form the basis of or be relied on in connection with any contract, commitment or A1: 22 77 146 investment decision in relation thereto in India, the United States or any other jurisdiction. A2: 129 129 129 • Prospective and existing investors should make their own evaluation of the Company as the information provided here does not purport to be all inclusive or to contain A3: 0 180 141 all of the information a prospective or existing investor may desire. Interested parties shall conduct their own due diligence and investigation on the information, before A4: 0 72 57 relying and acting thereon. Company makes no representation or warranty as to the accuracy or completeness of this information and shall not have any liability for any A5: 74 144 228 representations (expressed or implied) regarding information contained in, or for any omissions from, this information or any other written or oral communications A6: 148 176 200 transmitted to the recipient in the course of its evaluation of the Company. A7: 206 231 254 • This presentation may contain certain "forward looking statements", which are based on certain assumptions and expectations of future events. Actual future A8: 218 219 221 performance, outcomes and results may differ materially from those expressed in forward‐looking statements as a result of a number of risks, uncertainties and For client assumptions. Though such forward‐looking statements are based on reasonable assumptions, it can give no assurance that such expectations will be met. Neither the A1: 22 77 146 Company nor any of its advisors or representatives assumes any responsibility to update forward-looking statements or to adapt them to future events or developments. For CS Note - Quality Care numbers are indicative and subject to statutory audit adjustments. Proforma numbers for combined entity are also subject to finalization A3: 0 180 141 and audit of the merged accounts. Actual amounts, losses or impact on net profit could materially differ from those that have been estimated. In addition, Highlight in tables other factors that could cause actual results to differ materially from those estimated include harmonization of accounting policies and practices. H1: 218 219 221 H2: 188 208 222 Merger became effective on July 1, 2026 forming Aster DM Quality Care Limited Page title 24 pt 22 77 146 Executed on schedule with zero operational friction, establishing the cultural foundation required to unlock long-term financial synergies Page subtitle 20pt non bold 22 77 146 On Time #GO GREATER Building one culture across the combined organisation Heading Merger Execution Guided by 8 tenets. United by purpose Font color – 22 77 146 Merger completed on schedule reflecting our disciplined execution Line: 22 77 146 Excel color scheme A1: 22 77 146 A2: 129 129 129 Sites A3: 0 180 141 Hospitals & offices coveredwith zero service disruption. A4: 0 72 57 A5: 74 144 228 A6: 148 176 200 4,000+ A7: 206 231 254 Key Leaders Aligned A8: 218 219 221 Doctors & senior executives engaged through leadership webinar on day-1 For client A1: 22 77 146 45,000+ For CS A3: 0 180 141 Celebration Kits Delivered Enterprise-wide adoption of single brand & operating framework. Highlight in tables H1: 218 219 221 A structured cultural integration programme driving employee engagement, shared behaviors & long-term integration success H2: 188 208 222 Creating a larger platform to make quality healthcare accessible Page title 24 pt 22 77 146 Page subtitle 20pt non bold 22 77 146 35% - Metro and Tier 1 10,898 28 9 Capacity Beds 65% -Tier 2 & Tier 3 Heading Cities States Font color – 22 77 146 Line: 22 77 146 Excel color scheme International Hospitals: 2, Beds: 620 A1: 22 77 146 321 Labs & PECs3 and A2: 129 129 129 Hospitals 2054 Pharmacies A3: 0 180 141 Madhya Pradesh Dhaka Hospitals: 1, Beds: 222 Chhattisgarh A4: 0 72 57 Indore Hospitals: 1, Beds: 379 Chattogram A5: 74 144 228 Raipur Nagpur Bhubaneshwar Aurangabad A6: 148 176 200 Odisha A7: 206 231 254 Maharashtra Kolhapur H (5y hd ose pr ia tab lsa )d V (2i hs oa sk ph itaa lp s)atnam Hospitals: 1, Beds: 241 7,400+ 37,700+ Hospitals: 3, Beds: 693 Vijaywada (3 hospitals) Telangana Doctors5 Workforce5 Guntur A8: 218 219 221 Hospitals: 6, Beds: 1,240 Ongole Karnataka Andhra Pradesh For client Hospitals: 4, Beds: 1,329 Tirupati Hospitals: 8, Beds: 1,316 Bengaluru (3 hospitals) A1: 22 77 146 Kasargod Mandya Kannur Kozhikode Areekode Perinthalmanna ~8.0 Mn6 For CS Kerala7 Kochi Kottakkal Hospitals: 11, Beds: 4,642 Kottayam Tamil Nadu Kollam Total Patient Volume A3: 0 180 141 (2 hospitals) Hospitals: 1, Beds: 216 Trivandrum Nagercoil Notes: Highlight in tables 1. Presence and Operational metrics are as on June 30, 2026 2. Including WIMS. Count includes 4 O&M Asset Light hospital beds with a capacity of 608 beds 3. PECs: Patient Experience Centers H1: 218 219 221 4. Pharmacies in India operated by ARPPL under brand license from Aster 5. Including outsourced Employees, as on Mar'26 6. On TTM Basis H2: 188 208 222 7. Kerala hospital and bed count excludes WIMS Strategic rationale behind the merger Page title 24 pt 22 77 146 Page subtitle 20pt non bold 22 77 146 Heading ▪ 1. Scale Font color – 22 77 146 4. Diversification Line: 22 77 146 Merged entity as one of the top 3 hospital Geographically well diversified chains in India and with strong presence platform with low overlap in cities across South and Central India Excel color scheme of presence A1: 22 77 146 A2: 129 129 129 2. Enhanced Metrics 5. Growth Potential A3: 0 180 141 Strong financial, operational In-built growth potential with A4: 0 72 57 metrics and return metrics established hospitals in diverse A5: 74 144 228 being highly accretive for locations with room for investors brownfield and greenfield A6: 148 176 200 expansion A7: 206 231 254 A8: 218 219 221 3. Synergies 6. Backing of Global Marquee For client ▪ Combination to result in potential Investor synergies from revenue, procurement & A1: 22 77 146 Blackstone, world’s largest alternative supply chain, capex, and integration of asset manager, [Showing first 8,000 characters — download PDF for full document]